Tech
Tempus AI's data deals with BMS and Pathos provide for up to $192.5m over about five years
Bristol-Myers Squibb will pay $137.5m in fixed payments under an oncology contract running to 2031; Pathos AI will pay up to $55m, depending on neurology records delivered.